Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method
5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describ...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Journal of Pharmaceutical Analysis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177919308676 |
id |
doaj-4f102c1d02ab4108a7ca82fecdd8f130 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christelle Machon Frédéric Catez Nicole Dalla Venezia Floriane Vanhalle Laetitia Guyot Anne Vincent Maxime Garcia Béatrice Roy Jean-Jacques Diaz Jérôme Guitton |
spellingShingle |
Christelle Machon Frédéric Catez Nicole Dalla Venezia Floriane Vanhalle Laetitia Guyot Anne Vincent Maxime Garcia Béatrice Roy Jean-Jacques Diaz Jérôme Guitton Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method Journal of Pharmaceutical Analysis 5-Fluorouracil LC-MS-HRMS Nucleotide RNA DNA Incorporation rate |
author_facet |
Christelle Machon Frédéric Catez Nicole Dalla Venezia Floriane Vanhalle Laetitia Guyot Anne Vincent Maxime Garcia Béatrice Roy Jean-Jacques Diaz Jérôme Guitton |
author_sort |
Christelle Machon |
title |
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method |
title_short |
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method |
title_full |
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method |
title_fullStr |
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method |
title_full_unstemmed |
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method |
title_sort |
study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an lc-hrms method |
publisher |
Elsevier |
series |
Journal of Pharmaceutical Analysis |
issn |
2095-1779 |
publishDate |
2021-02-01 |
description |
5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describe the development of a method based on liquid chromatography coupled with high resolution mass spectrometry suitable for the simultaneous determination of the ten anabolic metabolites (nucleoside, nucleotide and sugar nucleotide) of 5-FU. The chromatographic separation was optimized on a porous graphitic carbon column allowing the analysis of the metabolites of 5-FU as well as endogenous nucleotides. The detection was performed on an Orbitrap® tandem mass spectrometer. Linearity of the method was verified in intracellular content and in RNA extracts. The limit of detection was equal to 12 pg injected on column for nucleoside metabolites of 5-FU and 150 pg injected on column for mono- and tri-phosphate nucleotide metabolites. Matrix effect was evaluated in cellular contents, DNA and RNA extracts for nucleoside and nucleotides metabolites. The method was successfully applied to i) measure the proportion of each anabolic metabolite of 5-FU in cellular contents, ii) follow the consequence of inhibition of enzymes on the endogenous nucleotide pools, iii) study the incorporation of metabolites of 5-FU into RNA and DNA, and iv) to determine the incorporation rate of 5-FUrd into 18 S and 28 S sub-units of rRNA. |
topic |
5-Fluorouracil LC-MS-HRMS Nucleotide RNA DNA Incorporation rate |
url |
http://www.sciencedirect.com/science/article/pii/S2095177919308676 |
work_keys_str_mv |
AT christellemachon studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT fredericcatez studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT nicoledallavenezia studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT florianevanhalle studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT laetitiaguyot studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT annevincent studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT maximegarcia studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT beatriceroy studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT jeanjacquesdiaz studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod AT jeromeguitton studyofintracellularanabolismof5fluorouracilandincorporationinnucleicacidsbasedonanlchrmsmethod |
_version_ |
1721547565010255872 |
spelling |
doaj-4f102c1d02ab4108a7ca82fecdd8f1302021-04-02T20:16:17ZengElsevierJournal of Pharmaceutical Analysis2095-17792021-02-011117787Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS methodChristelle Machon0Frédéric Catez1Nicole Dalla Venezia2Floriane Vanhalle3Laetitia Guyot4Anne Vincent5Maxime Garcia6Béatrice Roy7Jean-Jacques Diaz8Jérôme Guitton9Laboratoire de Chimie Analytique, Faculté de Pharmacie de Lyon, Université Lyon 1, 8 Avenue Rockefeller, Lyon, 69373, France; Laboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, France; Inserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceInstitut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS, Université de Montpellier, ENSCM, Campus Triolet, Montpellier, FranceInserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, FranceLaboratoire de Biochimie et de Pharmaco-toxicologie, Centre Hospitalier Lyon -Sud–HCL, Pierre Bénite, 69495, France; Inserm U1052, CNRS UMR5286 Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France. Centre Léon Bérard, F-69008 Lyon, France, Université de Lyon 1, F-69000 Lyon, France; Laboratoire de toxicologie, Faculté de pharmacie de Lyon, 8 avenue Rockefeller, F-69373 Lyon, France; Corresponding author. Laboratoire de Biochimie et de Pharmaco-toxicologie, Centre hospitalier Lyon-Sud – HCL, Pierre Bénite, 69495, France5-Fluorouracil (5-FU) is an anticancer drug extensively used for different cancers. Intracellular metabolic activation leads to several nucleoside and nucleotide metabolites essential to exert its cytotoxic activity on multiple cellular targets such as enzymes, DNA and RNA. In this paper, we describe the development of a method based on liquid chromatography coupled with high resolution mass spectrometry suitable for the simultaneous determination of the ten anabolic metabolites (nucleoside, nucleotide and sugar nucleotide) of 5-FU. The chromatographic separation was optimized on a porous graphitic carbon column allowing the analysis of the metabolites of 5-FU as well as endogenous nucleotides. The detection was performed on an Orbitrap® tandem mass spectrometer. Linearity of the method was verified in intracellular content and in RNA extracts. The limit of detection was equal to 12 pg injected on column for nucleoside metabolites of 5-FU and 150 pg injected on column for mono- and tri-phosphate nucleotide metabolites. Matrix effect was evaluated in cellular contents, DNA and RNA extracts for nucleoside and nucleotides metabolites. The method was successfully applied to i) measure the proportion of each anabolic metabolite of 5-FU in cellular contents, ii) follow the consequence of inhibition of enzymes on the endogenous nucleotide pools, iii) study the incorporation of metabolites of 5-FU into RNA and DNA, and iv) to determine the incorporation rate of 5-FUrd into 18 S and 28 S sub-units of rRNA.http://www.sciencedirect.com/science/article/pii/S20951779193086765-FluorouracilLC-MS-HRMSNucleotideRNADNAIncorporation rate |